Back
Neurocrine Biosciences Vs. Penumbra Industry Stock Comparison
Sell
41
NBIX
Neurocrine Biosciences
Last Price:
120.45
Seasonality Move:
9.9%
Buy
62
PEN
Penumbra
Last Price:
200.75
Seasonality Move:
-1.82%
Sell
41
Neurocrine Biosciences (NBIX)
is a Sell
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $119.85. The Score for NBIX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- NBIX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Penumbra (PEN)
is a Buy
Is Penumbra a Buy, Sell or Hold?
- The current Penumbra [PEN] share price is $195.58. The Score for PEN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- PEN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $119.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing selling pressure, which indicates risk of future bearish movement.
PEN Stock Price Chart
NBIX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.27 | Sell |
Relative Strength Index (14 RSI): | 30.83 | Sell |
Chaikin Money Flow: | -802737 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (119.79 - 147.07) | Sell |
Bollinger Bands (100): | (130.14 - 147.58) | Sell |
PEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.93 | Buy |
Relative Strength Index (14 RSI): | 51.19 | Buy |
Chaikin Money Flow: | 117030 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (190.35 - 204.35) | Sell |
Bollinger Bands (100): | (178.92 - 202.74) | Buy |
NBIX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 121.15 | Sell |
20-day SMA: | 129.92 | Sell |
50-day SMA: | 139.98 | Sell |
200-day SMA: | 136.32 | Sell |
8-day EMA: | 122.12 | Sell |
20-day EMA: | 127.93 | Sell |
50-day EMA: | 134.98 | Sell |
200-day EMA: | 133.19 | Sell |
PEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 194.84 | Buy |
20-day SMA: | 199.37 | Sell |
50-day SMA: | 189.56 | Buy |
200-day SMA: | 215.17 | Sell |
8-day EMA: | 194.23 | Buy |
20-day EMA: | 195.17 | Buy |
50-day EMA: | 192.46 | Buy |
200-day EMA: | 208.91 | Sell |
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.36 per share, an increase this year of $2.34 per share, and an increase next year of $1.55 per share.
Penumbra Earnings Growth & PEN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.27 per share, an increase this year of $0.56 per share, and an increase next year of $0.97 per share.
Neurocrine Biosciences Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Penumbra Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |